Provided by Tiger Trade Technology Pte. Ltd.

Kura Oncology

10.19
-0.4800-4.50%
Volume:410.76K
Turnover:4.23M
Market Cap:904.61M
PE:-3.03
High:10.52
Open:10.52
Low:10.19
Close:10.67
52wk High:13.90
52wk Low:7.36
Shares:88.77M
Float Shares:70.60M
Volume Ratio:0.81
T/O Rate:0.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3668
EPS(LYR):-3.1784
ROE:-167.71%
ROA:-31.30%
PB:18.68
PE(LYR):-3.21

Loading ...

Kura Oncology Reports Strong Clinical Activity and Safety with Darlifarnib + Adagrasib in KRAS G12C-Mutated Solid Tumors

GlobeNewswire
·
May 26

Kura Oncology Chief Commercial Officer Brian Powl sells 10,000 shares for $110,000

Reuters
·
May 23

Bank of America Securities Sticks to Their Buy Rating for Kura Oncology (KURA)

TIPRANKS
·
May 21

Kura Oncology CCO Brian Powl sells 339 shares worth $3,122.19

Reuters
·
May 21

Kura Oncology Chief Legal Officer Teresa Bair disposes 2,256 shares worth $21,159.19

Reuters
·
May 21

Kura Oncology COO Kathleen Ford sells 2,257 shares for $20,484.71

Reuters
·
May 21

Kura Oncology Earnings Call Signals Early Launch Strength

TIPRANKS
·
May 20

Kura Oncology joins TD Cowen Oncology Innovation Summit fireside chat

Reuters
·
May 20

Kura Oncology (KURA) Receives a Buy from LifeSci Capital

TIPRANKS
·
May 16

Kura Oncology (KURA) Q1 Loss Of US$73 Million Reinforces Bearish Profitability Concerns

Simply Wall St.
·
May 14

Lake Street Remains a Buy on Kura Oncology (KURA)

TIPRANKS
·
May 13

Analysts Offer Insights on Healthcare Companies: Kura Oncology (KURA) and Maze Therapeutics, Inc. (MAZE)

TIPRANKS
·
May 13

Kura Oncology reports Q1 EPS (83c), consensus (78c)

TIPRANKS
·
May 13

Kura Oncology Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 13

Kura Oncology Q1 Loss Widens, Revenue Rises

MT Newswires Live
·
May 13

Kura Oncology posts corporate presentation on KOMZIFTI launch and ziftomenib development strategy

Reuters
·
May 13

Earnings Flash (KURA) Kura Oncology Posts Q1 Per Share Loss $0.83, vs. FactSet Est of $0.83 Loss

MT Newswires Live
·
May 13

Kura Oncology Q1 FY26 net loss widens to $73.3 million; revenue rises to $18.3 million

Reuters
·
May 13

Kura Oncology Q1 EPS $(0.83) Beats $(0.94) Estimate, Sales $18.265M Miss $18.513M Estimate

Benzinga Earnings
·
May 13

Kura Oncology Q1 EPS USD -0.83

THOMSON REUTERS
·
May 13